Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer.
An estimated 20-65% of women treated with breast surgery for breast cancer experience
chronic pain in the treated breast. Patients will be randomize between: infiltration with
chlorhydrate of ropivacaine at the time of breast surgery for cancer versus
placebo.Intra-operative analgesia will be standardized as well as peri-operative pain
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Comparing the frequencies of chronic breast pain 3 months after breast surgery evaluated by the Brief Pain Inventory in the two groups.
3 months after surgery
Aline H Albi-Feldzer, MD
Centre René Huguenin - Saint-Cloud - France
France: Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)